Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations.
Front Immunol. 2023 Aug 22;14:1242508. doi: 10.3389/fimmu.2023.1242508. eCollection 2023.
Front Immunol. 2023.
PMID: 37675113
Free PMC article.
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.
Aliaga-Gaspar P, Hurtado-Guerrero I, Ciano-Petersen NL, Urbaneja P, Brichette-Mieg I, Reyes V, Rodriguez-Bada JL, Alvarez-Lafuente R, Arroyo R, Quintana E, Ramió-Torrentà L, Alonso A, Leyva L, Fernández O, Oliver-Martos B.
Aliaga-Gaspar P, et al.
Front Immunol. 2021 Dec 16;12:778204. doi: 10.3389/fimmu.2021.778204. eCollection 2021.
Front Immunol. 2021.
PMID: 34975865
Free PMC article.
Item in Clipboard
Cite
Cite